Added to YB: 2026-09-21
Pitch date: 2026-09-18
TEM [bullish]
Tempus AI, Inc.
Author Info
No bio for this author
Company Info
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$14.0B
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-81.71
P/E
-54.29
EV/Sales
10.25
Sector
Life Sciences Tools and Services
Category
growth
Tempus AI Is Ripping. Market Just Woke Up.
TEM (hold): Holding after buying at $55, with shares now around $80 for a 45% gain. Q2 2026 revenue rose 22% to $382.5M, oncology testing grew 31%, data licensing and modeling increased 36%, and guidance rose to ~$1.6B. The healthcare-data flywheel remains the thesis, but diagnostics is still the core business and valuation and 20-30% price swings make entry price important.
Read full article (2 min)